IPRIPR2021-01204Institution Denied
Revance Therapeutics, Inc.v.Medy-Tox, Inc.
IPR challenge of US 9480731.
Type
IPR
Filed
Jul 1, 2021
Instituted
Jan 19, 2022
Decided
Jan 19, 2022
Patent
Application
14567289
Inventor
Hyun Ho Jung et al
Granted
Nov 1, 2016
01
Timeline
3 milestones
2021-07-01Petition filed
2022-01-19Institution
2022-01-19Terminated
02
Parties & counsel
Petitioner
Revance Therapeutics, Inc.
Counsel
Ellison, Eldora et al
Patent Owner
Medy-Tox, Inc.
Counsel
Gates, Edward et al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →